Director, Incentive Compensation
Galderma
Summary
Galderma is seeking to hire an experienced individual to lead the Incentive Compensation team, within the Commercial Excellence team. The Director, Incentive Compensation, will be responsible for the design and administration of incentive compensation plans for all Galderma's business units. The ideal candidate will be a collaborative leader and have experience as both a manager and as an individual contributor.
Job description
The Opportunity
Galderma is seeking to hire an experienced individual to lead the Incentive Compensation team, within the Commercial Excellence team. The Director, Incentive Compensation, will be responsible for the design and administration of incentive compensation plans for all Galderma's business units. The ideal candidate will be a collaborative leader and have experience as both a manager and as an individual contributor.
Key Responsibilities
- Lead the Incentive Compensation (IC) team and be responsible and accountable for the design and on-going administration of sales incentive compensation plans.
- Ensure plans motivate field personnel and support the commercial sales objectives.
- Drive the design and adoption of "best in class" pharma industry compensation practices.
- Perform analysis on different compensation plan changes to understand the impact on the business and partner with sales leadership on the evolution of the compensation plans as the product matures.
- Identify and champion tool improvements, system automation, and data enhancements based on historical IC performance and feedback collected from the Sales leadership.
- Find opportunities to enhance Galderma's competitive advantage through innovative and motivating incentive strategies.
- Accurately establish fair and equitable measures of market opportunity and targets for sales territories, leveraging the best available market data sources; understand and proactively communicate any potential IC data/tracking-related challenges.
- Communicate quarterly accrual forecasts effectively to leadership, ensuring alignment between compensation plans and financial budgets.
- Ensure all plan designs are communicated accurately to maximize comprehension and engagement.
- Build appropriate and innovative IC reporting and tracking for key stakeholders.
- Maintain and ensure consistent compliance with a quarterly cadence IC calendar by leveraging highly effective organizational skills to facilitate timely submission of deliverables.
- Advise senior leadership of potential compliance risks and recommend appropriate action plans.
Qualifications
Education: Bachelor's degree in Finance, Business, or a related field, required, Master's degree strongly preferred.
Experience: 10+ years of Commercial Operations progressive experience, within a corporate environment is required, direct pharmaceutical manufacturer experience required.
- Strong experience and expertise within the incentive compensation construct, and demonstrated ability to successfully manage multiple compensation projects simultaneously.
- Strategic and innovative thinker with ability to build relationships with key internal leaders to achieve consensus or negotiate through complex challenges.
- Proven ability to lead a team working on complex business issues, finding creative options and innovative solutions in a constantly changing environment.
- Strong understanding of complex specialty markets (e.g. dermatology, injectables, immunology) with the ability to simplify complex content to ensure key messages are effectively delivered to customer stakeholders.
- Experience working with and reporting on syndicated prescription data, field force execution, and related national Wholesaler data sets (e.g. IQVIA, Veeva CRM, 852/867, HUB, SP Dispense).
- Advanced Excel skills and experience with data visualization tools (PowerBI, Tableau, etc.) required.
- High degree of attention to detail, and excellent written and communication skills.
- Proven track record of effective vendor management.
- Track record of creating scalable process improvements.
Requirements
- Bachelor's degree in Finance, Business, or a related field, required
- Master's degree strongly preferred
- 10+ years of Commercial Operations progressive experience, within a corporate environment is required
- Direct pharmaceutical manufacturer experience required
- Strong experience and expertise within the incentive compensation construct
- Demonstrated ability to successfully manage multiple compensation projects simultaneously
- Strategic and innovative thinker with ability to build relationships with key internal leaders
- Proven ability to lead a team working on complex business issues
- Strong understanding of complex specialty markets (e.g. dermatology, injectables, immunology)
- Experience working with and reporting on syndicated prescription data, field force execution, and related national Wholesaler data sets (e.g. IQVIA, Veeva CRM, 852/867, HUB, SP Dispense)
- Advanced Excel skills required
- Experience with data visualization tools (PowerBI, Tableau, etc.) required
- High degree of attention to detail
- Excellent written and communication skills
- Proven track record of effective vendor management
- Track record of creating scalable process improvements
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Paid Time Off
- Annual Incentive Program
Company overview
Galderma S.A. is a Swiss pharmaceutical company headquartered in Zug, Switzerland, specializing exclusively in dermatology. Founded in 1981 as a joint venture between L'Oréal and Nestlé, the company has evolved into the world's largest independent dermatology company. Galderma focuses on three core business segments: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. The company offers a comprehensive portfolio of premium brands including Cetaphil, Restylane, Azzalure, Dysport, and Sculptra, serving patients and consumers in over 100 countries. With approximately 6,500 employees globally, Galderma maintains a strong research and development presence across six sites worldwide. The company went public in 2024 with an IPO on the SIX Swiss Exchange, marking a significant milestone in its growth trajectory. Galderma's mission is to advance dermatology for every skin story, combining scientific innovation with trusted partnerships with healthcare professionals to deliver superior outcomes for diverse skin needs.